Charles Balch, MD, was honored with the Lifetime Achievement Yvonne Award during the Yvonne Awards Ceremony at OncoDaily Party 2026, held on May 29 at Park West in Chicago.
Natera was the exclusive partner of the Yvonne Awards Ceremony and OncoDaily Reception.
The recognition celebrates Dr. Balch’s extraordinary career as a clinical and academic surgical oncologist, international leader, editor, educator, and one of the most influential figures in melanoma and breast cancer surgery. Over more than four decades, his work has helped shape surgical oncology as a discipline, advanced evidence-based cancer care, strengthened oncology institutions, and expanded the global exchange of knowledge across cancer research and clinical practice.
The Lifetime Achievement Yvonne Award recognizes leaders whose careers have left a lasting mark on oncology. In Dr. Balch’s case, that legacy extends across patient care, melanoma staging and treatment, breast cancer surgery, tumor immunology, academic leadership, oncology publishing, professional societies, and mentorship of generations of surgical oncologists.
A Career That Helped Define Modern Surgical Oncology
Charles Balch has led a distinguished career as a clinical and academic surgical oncologist for more than 40 years. He is widely recognized as a leading authority in both melanoma and breast cancer, while also contributing to laboratory research in tumor immunology and human T lymphocyte differentiation.
His academic path began with a Bachelor of Science in Immunology from the University of Toledo, followed by a medical degree from the Columbia College of Physicians and Surgeons. He completed surgical internship training at Duke University Medical Center, surgical residency at the University of Alabama at Birmingham, and a research fellowship in immunology at the Scripps Clinic and Research Foundation.
This combination of surgery and immunology became central to his professional identity. At a time when cancer surgery, systemic therapy, and tumor biology were still developing as more integrated fields, Dr. Balch helped bring scientific depth and multidisciplinary thinking into surgical oncology.
Leadership at Major Cancer Institutions
Charles Balch’s leadership has shaped several major oncology institutions in the United States. At The University of Texas MD Anderson Cancer Center, he served as Head of the Division of Surgery and Anesthesiology, Chairman of the Department of Surgical Oncology, Vice President for Hospital and Clinics, Executive Vice President for Health Affairs, and other senior leadership roles.
He later served as President and CEO of City of Hope National Medical Center from 1996 to 1999, and as Executive Vice President and Chief Executive Officer of the American Society of Clinical Oncology from 2000 to 2005.
At Johns Hopkins, he held roles as Professor in Surgery, Oncology, and Dermatology, Deputy Director for Clinical Trials and Outcomes Research, and Founding Director of the Johns Hopkins Clinical Research Network.
These positions reflect the scale of his influence. Dr. Balch did not only contribute as a surgeon and investigator; he helped guide institutions, build clinical research infrastructure, support multidisciplinary care, and strengthen the professional organizations that shape oncology practice.
A Global Authority in Melanoma
Melanoma has been one of the defining areas of Dr. Balch’s career. His work has contributed to the evolution of melanoma staging, surgical management, sentinel lymph node evaluation, lymphadenectomy trials, prognosis, clinical guidelines, and evidence-based treatment decisions.
His lectures and presentations have addressed topics such as melanoma staging, sentinel lymph node biopsy, completion lymphadenectomy, prognostic factors, surgical treatment, adjuvant therapy, and the future of melanoma care. He has presented across the United States and internationally, reflecting his role as a global educator in the field.
For generations of surgical oncologists, melanoma has served as a model for how clinical staging, pathology, surgical decision-making, systemic treatment, and clinical trials can come together to refine cancer care. Dr. Balch has been one of the central voices in that evolution.
Contributions to Breast Cancer Surgery and Multidisciplinary Care
Alongside melanoma, Dr. Charles Balch has also been a major figure in breast cancer surgery. His work and educational activities have addressed management of axillary lymph nodes, sentinel node biopsy after chemotherapy, ductal carcinoma in situ, and the establishment of multidisciplinary breast centers.
These themes remain highly relevant today. Breast cancer care depends on coordination across surgery, pathology, imaging, radiation oncology, medical oncology, genetics, survivorship, and patient-centered decision-making. Dr. Balch’s long-standing focus on multidisciplinary care helped support a model that is now central to modern oncology practice.
A Record of Scientific Productivity and Influence
Charles Balch is the author of more than 760 publications, which have been cited more than 24,000 times in the biomedical literature. His h-index is listed as 73, reflecting the broad and lasting influence of his scientific work.
His research has included melanoma, breast cancer, surgical oncology, tumor immunology, clinical trials, human T lymphocyte differentiation, and cancer care delivery. He has also served as Principal Investigator on major grants, including NIH/NCI-funded work on melanoma surgical protocols, surgical oncology training, clinical and laboratory research training for surgical oncologists, and immunologic studies.
This research record reflects a career that connected clinical questions with scientific investigation. Dr. Balch’s work helped generate evidence, train investigators, and support the academic foundations of surgical oncology.
Founding Editor of a Leading Surgical Oncology Journal
One of Dr. Charles Balch’s most enduring contributions is his work in oncology publishing. He is the founding Editor-in-Chief of Annals of Surgical Oncology, a journal recognized internationally as a leading publication in surgical oncology.
Through this role, Dr. Charles Balch helped create a platform for surgical oncology research, clinical trials, guidelines, reviews, and educational scholarship. The journal has served as an important home for the field, supporting the academic identity of surgical oncology and giving investigators a place to publish work directly relevant to cancer surgery.
He has also served as Editor-in-Chief for Patient Resource Cancer Guides, which distribute more than one million cancer guides each year to patients, with multiple titles covering different cancer topics.
This patient-facing work reflects another dimension of his career: making cancer information accessible beyond academic audiences.
Service to Oncology Societies and Global Cancer Communities
Dr. Balch’s professional service has included leadership and membership across major cancer organizations, including the American Society of Clinical Oncology, Society of Surgical Oncology, American Joint Committee on Cancer, American College of Surgeons, National Comprehensive Cancer Network, and international surgical oncology societies.
He has lectured in more than 42 countries, bringing expertise in melanoma, breast cancer, surgical oncology, evidence-based medicine, clinical guidelines, academic surgery, and professional development to audiences around the world.
His career reflects the global nature of surgical oncology. Cancer surgery has advanced through international collaboration, shared evidence, clinical trials, staging systems, and professional education. Dr. Balch has been a major contributor to that global exchange.
Honors Reflecting a Lifetime of Impact
Charles Balch has received numerous honors recognizing his leadership and contributions to oncology. These include the Lifetime Achievement Award from the British Association of Surgical Oncology, the Heritage Award from the Society of Surgical Oncology, the Lifetime Achievement Award from the American Skin Association, the Special Recognition Award and Statesman Award from ASCO, and an Honorary PhD Doctorate from the University of Crete.
He has also received honorary fellowships and memberships from surgical oncology organizations in Japan, Brazil, Australia, Latin America, Europe, Israel, Greece, Italy, and the United Kingdom. These recognitions speak to the international reach of his work and the respect he has earned across the global surgical oncology community.
Mentorship, Academic Development, and Professional Legacy
Charles Balch’s legacy also includes mentorship and academic development. His invited lectures have addressed not only melanoma and breast cancer, but also academic surgery, manuscript writing, career development, faculty promotion, burnout, wellness, and professional growth.
These topics reflect a career invested in the people who carry oncology forward. Training the next generation of surgical oncologists requires more than technical teaching. It requires guidance in scholarship, leadership, resilience, communication, and building a meaningful academic career.
Honoring a Lifetime of Leadership in Cancer Care
The Lifetime Achievement Yvonne Award recognizes Dr. Charles M. Balch for a career that has shaped surgical oncology through clinical excellence, research, institutional leadership, publishing, professional service, and global education.
At OncoDaily Party 2026, his recognition highlighted the importance of leaders whose work becomes part of the foundation of a field. Dr. Balch’s contributions to melanoma, breast cancer, surgical oncology training, academic publishing, cancer patient education, and oncology leadership continue to influence clinicians, researchers, institutions, and patients worldwide.
Through his work at MD Anderson Cancer Center, City of Hope, Johns Hopkins, ASCO, Annals of Surgical Oncology, and international surgical oncology communities, Dr. Balch’s career stands as a model of sustained impact in cancer care.
Written by Nare Hovhannisyan, MD